Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="gravitate-ips-jp"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/Bundle-uv-ips"/>
</meta>
<identifier>
<system value="https://www.gravitatehealth.eu/sid/doc"/>
<value value="ips-jp"/>
</identifier>
<type value="document"/>
<timestamp value="2021-09-03T08:38:00+02:00"/>
<entry>
<fullUrl
value="https://myserver.org/Composition/2fa5b223-ebce-4f39-9c66-5dc014f7359c"/>
<resource>
<Composition>
<id value="ips-example-2"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/Composition-uv-ips"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Composition_ips-example-2"> </a>
<b>Id:</b>
ips-example-2
<br/>
<b>status:</b>
Final
<br/>
<b>Type:</b>
Patient summary Document
<br/>
<b>Subject:</b>
<a>IPS-JP</a>
<br/>
<b>Sections:</b>
<br/>
<ul>
<li>
Medication Summary
</li>
<ul>
<li>
Ogivri trastuzumab 150 mg powder for concentrate for solution for infusion
</li>
<li>
Lipcut Simvastatin 20 mg tablet
</li>
<li>
Enbrel Etanercept 25 mg powder for solution for injection
</li>
<li>
Tegretol Carbamazepine 200 mg tablets
</li>
</ul>
<li>
Allergies and Intolerances
</li>
<ul>
<li>
No infos about Allergies
</li>
</ul>
<li>
Problem List
</li>
<ul>
<li>
Malignant neoplasm of breast (disorder)
</li>
<li>
Hypercholesterolemia
</li>
<li>
Rheumatoid arthritis
</li>
<li>
Epilepsy (disorder)
</li>
</ul>
</ul>
</div>
</text>
<status value="final"/>
<type>
<coding>
<system value="http://loinc.org"/>
<code value="60591-5"/>
<display value="Patient summary Document"/>
</coding>
</type>
<subject>
<reference value="Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<display value="IPS-JP"/>
</subject>
<date value="2018-07-10T15:22:00+02:00"/>
<author>
<reference
value="Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d9c"/>
<display value="Dr. JP"/>
</author>
<title value="Patient Summary (IPSJP)"/>
<confidentiality value="N"/>
<section>
<title value="Medication Summary"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="10160-0"/>
<display value="Hx of Medication use"/>
</coding>
</code>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Ogivri trastuzumab 150 mg powder for concentrate for solution for infusion</li></ul><ul><li>Lipcut Simvastatin 20 mg tablet</li></ul><ul><li>Enbrel Etanercept 25 mg powder for solution for injection</li></ul><ul><li>Tegretol Carbamazepine 200 mg tablets</li></ul></div>
</text>
<entry>
<reference
value="MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a899c"/>
<display
value="Ogivri trastuzumab 150 mg powder for concentrate for solution for infusion"/>
</entry>
<entry>
<reference
value="MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78f9c"/>
<display value="Lipcut Simvastatin 20 mg tablet"/>
</entry>
<entry>
<reference
value="MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87b9c"/>
<display
value="Enbrel Etanercept 25 mg powder for solution for injection"/>
</entry>
<entry>
<reference
value="MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade94g9c"/>
<display value="Tegretol Carbamazepine 200 mg tablets"/>
</entry>
</section>
<section>
<title value="Allergies and Intolerances"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="48765-2"/>
<display value="Allergies and adverse reactions Document"/>
</coding>
</code>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><ul><li>No infos about Allergies</li></ul></div>
</text>
<entry>
<reference
value="AllergyIntolerance/0dff4474-fa08-4f45-8260-dbb23094bf09c"/>
<display value="No infos about Allergies"/>
</entry>
</section>
<section>
<title value="Problem List"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="11450-4"/>
<display value="Problem list Reported"/>
</coding>
</code>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Malignant neoplasm of breast (disorder)</li></ul><ul><li>Hypercholesterolemia</li></ul><ul><li>Rheumatoid arthritis</li></ul><ul><li>Epilepsy</li></ul></div>
</text>
<entry>
<reference
value="Condition/bcc79261-142c-48ec-b032-f3f9af49ec59c"/>
<display value="Malignant neoplasm of breast (disorder)"/>
</entry>
<entry>
<reference
value="Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5139c"/>
<display value="Hypercholesterolemia"/>
</entry>
<entry>
<reference
value="Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6259c"/>
<display value="Rheumatoid arthritis"/>
</entry>
<entry>
<reference
value="Condition/f06b7cf8-c15c-4288-a0f9-45a1026e6789c"/>
<display value="Epilepsy (disorder)"/>
</entry>
</section>
</Composition>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<resource>
<Patient>
<id value="c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c"> </a><p class="res-header-id"><b>Generated Narrative: Patient c154158f-6a43-4ab7-8443-e7f4bf915dd9c</b></p><a name="c154158f-6a43-4ab7-8443-e7f4bf915dd9c"> </a><a name="hcc154158f-6a43-4ab7-8443-e7f4bf915dd9c"> </a><a name="c154158f-6a43-4ab7-8443-e7f4bf915dd9c-en-US"> </a><p style="border: 1px #661aff solid; background-color: #e6e6ff; padding: 10px;">IPS-JP Gravitate Female, DoB: 1946-05-05 ( https://www.gravitatehealth.eu/sid/doc#ips-jp)</p><hr/><table class="grid"><tr><td style="background-color: #f3f5da" title="Record is active">Active:</td><td colspan="3">true</td></tr></table></div>
</text>
<identifier>
<system value="https://www.gravitatehealth.eu/sid/doc"/>
<value value="ips-jp"/>
</identifier>
<active value="true"/>
<name>
<family value="Gravitate"/>
<given value="IPS-JP"/>
</name>
<gender value="female"/>
<birthDate value="1946-05-05"/>
</Patient>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d9c"/>
<resource>
<Practitioner>
<id value="1ece89c5-fda3-4db9-ace6-decbe6c603d9c"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d9c"> </a><p class="res-header-id"><b>Generated Narrative: Practitioner 1ece89c5-fda3-4db9-ace6-decbe6c603d9c</b></p><a name="1ece89c5-fda3-4db9-ace6-decbe6c603d9c"> </a><a name="hc1ece89c5-fda3-4db9-ace6-decbe6c603d9c"> </a><a name="1ece89c5-fda3-4db9-ace6-decbe6c603d9c-en-US"> </a><p><b>name</b>: IPS JP </p></div>
</text>
<name>
<family value="JP"/>
<given value="IPS"/>
<prefix value="Dr."/>
</name>
</Practitioner>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/AllergyIntolerance/0dff4474-fa08-4f45-8260-dbb23094bf09c"/>
<resource>
<AllergyIntolerance>
<id value="0dff4474-fa08-4f45-8260-dbb23094bf09c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/AllergyIntolerance-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="AllergyIntolerance_0dff4474-fa08-4f45-8260-dbb23094bf09c"> </a><p class="res-header-id"><b>Generated Narrative: AllergyIntolerance 0dff4474-fa08-4f45-8260-dbb23094bf09c</b></p><a name="0dff4474-fa08-4f45-8260-dbb23094bf09c"> </a><a name="hc0dff4474-fa08-4f45-8260-dbb23094bf09c"> </a><a name="0dff4474-fa08-4f45-8260-dbb23094bf09c-en-US"> </a><p><b>clinicalStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical active}">Active</span></p><p><b>verificationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-verification confirmed}">Confirmed</span></p><p><b>code</b>: <span title="Codes:{http://hl7.org/fhir/uv/ips/CodeSystem/absent-unknown-uv-ips no-allergy-info}">no-allergy-info</span></p><p><b>patient</b>: <a href="Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c">IPS-JP</a></p></div>
</text>
<clinicalStatus>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical"/>
<code value="active"/>
</coding>
</clinicalStatus>
<verificationStatus>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/allergyintolerance-verification"/>
<code value="confirmed"/>
</coding>
</verificationStatus>
<code>
<coding>
<system
value="http://hl7.org/fhir/uv/ips/CodeSystem/absent-unknown-uv-ips"/>
<code value="no-allergy-info"/>
</coding>
</code>
<patient>
<reference value="Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<display value="IPS-JP"/>
</patient>
</AllergyIntolerance>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Condition/bcc79261-142c-48ec-b032-f3f9af49ec59c"/>
<resource>
<Condition>
<id value="bcc79261-142c-48ec-b032-f3f9af49ec59c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Condition_bcc79261-142c-48ec-b032-f3f9af49ec59c"> </a><p class="res-header-id"><b>Generated Narrative: Condition bcc79261-142c-48ec-b032-f3f9af49ec59c</b></p><a name="bcc79261-142c-48ec-b032-f3f9af49ec59c"> </a><a name="hcbcc79261-142c-48ec-b032-f3f9af49ec59c"> </a><a name="bcc79261-142c-48ec-b032-f3f9af49ec59c-en-US"> </a><p><b>clinicalStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/condition-clinical active}">Active</span></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 254837009}">Malignant neoplasm of breast</span></p><p><b>subject</b>: <a href="Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c">IPS-JP</a></p><p><b>asserter</b>: <a href="Bundle-gravitate-ips-jp.html#Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d9c">Dr. IPS-JP</a></p></div>
</text>
<clinicalStatus>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/condition-clinical"/>
<code value="active"/>
</coding>
</clinicalStatus>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="254837009"/>
<display value="Malignant neoplasm of breast (disorder)"/>
</coding>
<text value="Malignant neoplasm of breast"/>
</code>
<subject>
<reference value="Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<display value="IPS-JP"/>
</subject>
<asserter>
<reference
value="Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d9c"/>
<display value="Dr. IPS-JP"/>
</asserter>
</Condition>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6259c"/>
<resource>
<Condition>
<id value="a4a9d90a-d1b0-4d60-82f0-c52343dc6259c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Condition_a4a9d90a-d1b0-4d60-82f0-c52343dc6259c"> </a><p class="res-header-id"><b>Generated Narrative: Condition a4a9d90a-d1b0-4d60-82f0-c52343dc6259c</b></p><a name="a4a9d90a-d1b0-4d60-82f0-c52343dc6259c"> </a><a name="hca4a9d90a-d1b0-4d60-82f0-c52343dc6259c"> </a><a name="a4a9d90a-d1b0-4d60-82f0-c52343dc6259c-en-US"> </a><p><b>clinicalStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/condition-clinical active}">Active</span></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 69896004}">Rheumatoid arthritis</span></p><p><b>subject</b>: <a href="Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c">IPS-JP</a></p><p><b>onset</b>: 2015</p><p><b>asserter</b>: <a href="Bundle-gravitate-ips-jp.html#Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d9c">Dr. IPS-JP</a></p></div>
</text>
<clinicalStatus>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/condition-clinical"/>
<code value="active"/>
</coding>
</clinicalStatus>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="69896004"/>
<display value="Rheumatoid arthritis (disorder)"/>
</coding>
<text value="Rheumatoid arthritis"/>
</code>
<subject>
<reference value="Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<display value="IPS-JP"/>
</subject>
<onsetDateTime value="2015"/>
<asserter>
<reference
value="Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d9c"/>
<display value="Dr. IPS-JP"/>
</asserter>
</Condition>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5139c"/>
<resource>
<Condition>
<id value="f06b7cf8-c15c-4288-a0f9-45a1026e5139c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Condition_f06b7cf8-c15c-4288-a0f9-45a1026e5139c"> </a><p class="res-header-id"><b>Generated Narrative: Condition f06b7cf8-c15c-4288-a0f9-45a1026e5139c</b></p><a name="f06b7cf8-c15c-4288-a0f9-45a1026e5139c"> </a><a name="hcf06b7cf8-c15c-4288-a0f9-45a1026e5139c"> </a><a name="f06b7cf8-c15c-4288-a0f9-45a1026e5139c-en-US"> </a><p><b>clinicalStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/condition-clinical active}">Active</span></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 13644009}">Hypercholesterolemia</span></p><p><b>subject</b>: <a href="Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c">IPS-JP</a></p><p><b>onset</b>: 1993</p></div>
</text>
<clinicalStatus>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/condition-clinical"/>
<code value="active"/>
</coding>
</clinicalStatus>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="13644009"/>
<display value="Hypercholesterolemia (disorder)"/>
</coding>
<text value="Hypercholesterolemia"/>
</code>
<subject>
<reference value="Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<display value="IPS-JP"/>
</subject>
<onsetDateTime value="1993"/>
</Condition>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Condition/f06b7cf8-c15c-4288-a0f9-45a1026e6789c"/>
<resource>
<Condition>
<id value="f06b7cf8-c15c-4288-a0f9-45a1026e6789c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Condition_f06b7cf8-c15c-4288-a0f9-45a1026e6789c"> </a><p class="res-header-id"><b>Generated Narrative: Condition f06b7cf8-c15c-4288-a0f9-45a1026e6789c</b></p><a name="f06b7cf8-c15c-4288-a0f9-45a1026e6789c"> </a><a name="hcf06b7cf8-c15c-4288-a0f9-45a1026e6789c"> </a><a name="f06b7cf8-c15c-4288-a0f9-45a1026e6789c-en-US"> </a><p><b>clinicalStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/condition-clinical active}">Active</span></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 84757009}">Epilepsy</span></p><p><b>subject</b>: <a href="Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c">IPS-JP</a></p><p><b>onset</b>: 1993</p></div>
</text>
<clinicalStatus>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/condition-clinical"/>
<code value="active"/>
</coding>
</clinicalStatus>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="84757009"/>
<display value="Epilepsy (disorder)"/>
</coding>
<text value="Epilepsy"/>
</code>
<subject>
<reference value="Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<display value="IPS-JP"/>
</subject>
<onsetDateTime value="1993"/>
</Condition>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a899c"/>
<resource>
<MedicationStatement>
<id value="29074ca4-efcb-4ff4-8446-feed2399a899c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/MedicationStatement-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicationStatement_29074ca4-efcb-4ff4-8446-feed2399a899c"> </a><p class="res-header-id"><b>Generated Narrative: MedicationStatement 29074ca4-efcb-4ff4-8446-feed2399a899c</b></p><a name="29074ca4-efcb-4ff4-8446-feed2399a899c"> </a><a name="hc29074ca4-efcb-4ff4-8446-feed2399a899c"> </a><a name="29074ca4-efcb-4ff4-8446-feed2399a899c-en-US"> </a><p><b>status</b>: Active</p><p><b>medication</b>: <a href="Bundle-gravitate-ips-jp.html#Medication_b50ae644-e0b7-4007-809f-26f493cbe369c">trastuzumab</a></p><p><b>subject</b>: <a href="Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c">IPS-JP</a></p><p><b>effective</b>: 2015</p><h3>Dosages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Route</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://standardterms.edqm.eu 20045000}">Intravenous use</span></td></tr></table></div>
</text>
<status value="active"/>
<medicationReference>
<reference
value="Medication/b50ae644-e0b7-4007-809f-26f493cbe369c"/>
<display value="trastuzumab"/>
</medicationReference>
<subject>
<reference value="Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<display value="IPS-JP"/>
</subject>
<effectiveDateTime value="2015"/>
<dosage>
<route>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="20045000"/>
<display value="Intravenous use"/>
</coding>
</route>
</dosage>
</MedicationStatement>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78f9c"/>
<resource>
<MedicationStatement>
<id value="f6cb1218-f81c-4338-80d8-3c10910f78f9c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/MedicationStatement-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicationStatement_f6cb1218-f81c-4338-80d8-3c10910f78f9c"> </a><p class="res-header-id"><b>Generated Narrative: MedicationStatement f6cb1218-f81c-4338-80d8-3c10910f78f9c</b></p><a name="f6cb1218-f81c-4338-80d8-3c10910f78f9c"> </a><a name="hcf6cb1218-f81c-4338-80d8-3c10910f78f9c"> </a><a name="f6cb1218-f81c-4338-80d8-3c10910f78f9c-en-US"> </a><p><b>status</b>: Active</p><p><b>medication</b>: <a href="Bundle-gravitate-ips-jp.html#Medication_de131e15-ed13-4b31-b38c-3204a84d99c9c">simvastatin</a></p><p><b>subject</b>: <a href="Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c">IPS-JP</a></p><p><b>effective</b>: 2020</p><h3>Dosages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Route</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://standardterms.edqm.eu 20053000}">Oral use</span></td></tr></table></div>
</text>
<status value="active"/>
<medicationReference>
<reference
value="Medication/de131e15-ed13-4b31-b38c-3204a84d99c9c"/>
<display value="simvastatin"/>
</medicationReference>
<subject>
<reference value="Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<display value="IPS-JP"/>
</subject>
<effectiveDateTime value="2020"/>
<dosage>
<route>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="20053000"/>
<display value="Oral use"/>
</coding>
</route>
</dosage>
</MedicationStatement>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87b9c"/>
<resource>
<MedicationStatement>
<id value="f26084c9-b1c8-46d9-acb2-1d400ade87b9c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/MedicationStatement-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicationStatement_f26084c9-b1c8-46d9-acb2-1d400ade87b9c"> </a><p class="res-header-id"><b>Generated Narrative: MedicationStatement f26084c9-b1c8-46d9-acb2-1d400ade87b9c</b></p><a name="f26084c9-b1c8-46d9-acb2-1d400ade87b9c"> </a><a name="hcf26084c9-b1c8-46d9-acb2-1d400ade87b9c"> </a><a name="f26084c9-b1c8-46d9-acb2-1d400ade87b9c-en-US"> </a><p><b>status</b>: Active</p><p><b>medication</b>: <a href="Bundle-gravitate-ips-jp.html#Medication_9ac3356c-4ea4-4814-84c3-235484f2ef19c">enbrel</a></p><p><b>subject</b>: <a href="Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c">IPS-JP</a></p><p><b>effective</b>: 2023</p><h3>Dosages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Route</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://standardterms.edqm.eu 20066000}">Subcutaneous use</span></td></tr></table></div>
</text>
<status value="active"/>
<medicationReference>
<reference
value="Medication/9ac3356c-4ea4-4814-84c3-235484f2ef19c"/>
<display value="enbrel"/>
</medicationReference>
<subject>
<reference value="Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<display value="IPS-JP"/>
</subject>
<effectiveDateTime value="2023"/>
<dosage>
<route>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="20066000"/>
<display value="Subcutaneous use"/>
</coding>
</route>
</dosage>
</MedicationStatement>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade94g9c"/>
<resource>
<MedicationStatement>
<id value="f26084c9-b1c8-46d9-acb2-1d400ade94g9c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/MedicationStatement-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicationStatement_f26084c9-b1c8-46d9-acb2-1d400ade94g9c"> </a><p class="res-header-id"><b>Generated Narrative: MedicationStatement f26084c9-b1c8-46d9-acb2-1d400ade94g9c</b></p><a name="f26084c9-b1c8-46d9-acb2-1d400ade94g9c"> </a><a name="hcf26084c9-b1c8-46d9-acb2-1d400ade94g9c"> </a><a name="f26084c9-b1c8-46d9-acb2-1d400ade94g9c-en-US"> </a><p><b>status</b>: Active</p><p><b>medication</b>: <a href="Bundle-gravitate-ips-jp.html#Medication_9ac3356c-4ea4-4814-84c3-235484f2jk99c">carbamazepine</a></p><p><b>subject</b>: <a href="Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c">IPS-JP</a></p><p><b>effective</b>: 2020</p><h3>Dosages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Route</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://standardterms.edqm.eu 20053000}">Oral use</span></td></tr></table></div>
</text>
<status value="active"/>
<medicationReference>
<reference
value="Medication/9ac3356c-4ea4-4814-84c3-235484f2jk99c"/>
<display value="carbamazepine"/>
</medicationReference>
<subject>
<reference value="Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c"/>
<display value="IPS-JP"/>
</subject>
<effectiveDateTime value="2020"/>
<dosage>
<route>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="20053000"/>
<display value="Oral use"/>
</coding>
</route>
</dosage>
</MedicationStatement>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Medication/b50ae644-e0b7-4007-809f-26f493cbe369c"/>
<resource>
<Medication>
<id value="b50ae644-e0b7-4007-809f-26f493cbe369c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/Medication-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Medication_b50ae644-e0b7-4007-809f-26f493cbe369c"> </a><p class="res-header-id"><b>Generated Narrative: Medication b50ae644-e0b7-4007-809f-26f493cbe369c</b></p><a name="b50ae644-e0b7-4007-809f-26f493cbe369c"> </a><a name="hcb50ae644-e0b7-4007-809f-26f493cbe369c"> </a><a name="b50ae644-e0b7-4007-809f-26f493cbe369c-en-US"> </a><p><b>code</b>: <span title="Codes:{http://iyaku.info/medicine/ 4291447D2024}">4291447D2024</span></p><p><b>form</b>: <span title="Codes:{http://standardterms.edqm.eu 50042000}">Powder and solvent for concentrate for solution for infusion</span></p><h3>Ingredients</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fdasis.nlm.nih.gov P188ANX8CK}">trastuzumab</span></td></tr></table></div>
</text>
<code>
<coding>
<system value="http://iyaku.info/medicine/"/>
<code value="4291447D2024"/>
</coding>
</code>
<form>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="50042000"/>
<display
value="Powder and solvent for concentrate for solution for infusion"/>
</coding>
</form>
<ingredient>
<itemCodeableConcept>
<coding>
<system value="http://fdasis.nlm.nih.gov"/>
<code value="P188ANX8CK"/>
<display value="trastuzumab"/>
</coding>
<text value="trastuzumab"/>
</itemCodeableConcept>
</ingredient>
</Medication>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Medication/de131e15-ed13-4b31-b38c-3204a84d99c9c"/>
<resource>
<Medication>
<id value="de131e15-ed13-4b31-b38c-3204a84d99c9c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/Medication-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Medication_de131e15-ed13-4b31-b38c-3204a84d99c9c"> </a><p class="res-header-id"><b>Generated Narrative: Medication de131e15-ed13-4b31-b38c-3204a84d99c9c</b></p><a name="de131e15-ed13-4b31-b38c-3204a84d99c9c"> </a><a name="hcde131e15-ed13-4b31-b38c-3204a84d99c9c"> </a><a name="de131e15-ed13-4b31-b38c-3204a84d99c9c-en-US"> </a><p><b>code</b>: <span title="Codes:{http://iyaku.info/medicine/ 2189011F1262}, {https://www.who-umc.org/phpid F92168108C432D63DACDD70444176BB3}">Lipcut Simvastatin 5 mg tablet</span></p><p><b>form</b>: <span title="Codes:{http://standardterms.edqm.eu 10219000}">Tablet</span></p><h3>Ingredients</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fdasis.nlm.nih.gov AGG2FN16EV}">SIMVASTATIN</span></td></tr></table></div>
</text>
<code>
<coding>
<system value="http://iyaku.info/medicine/"/>
<code value="2189011F1262"/>
</coding>
<coding>
<system value="https://www.who-umc.org/phpid"/>
<code value="F92168108C432D63DACDD70444176BB3"/>
<display value="Lipcut Simvastatin 5 mg tablet"/>
</coding>
</code>
<form>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="10219000"/>
<display value="Tablet"/>
</coding>
</form>
<ingredient>
<itemCodeableConcept>
<coding>
<system value="http://fdasis.nlm.nih.gov"/>
<code value="AGG2FN16EV"/>
<display value="SIMVASTATIN"/>
</coding>
<text value="SIMVASTATIN"/>
</itemCodeableConcept>
</ingredient>
</Medication>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Medication/9ac3356c-4ea4-4814-84c3-235484f2ef19c"/>
<resource>
<Medication>
<id value="9ac3356c-4ea4-4814-84c3-235484f2ef19c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/Medication-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Medication_9ac3356c-4ea4-4814-84c3-235484f2ef19c"> </a><p class="res-header-id"><b>Generated Narrative: Medication 9ac3356c-4ea4-4814-84c3-235484f2ef19c</b></p><a name="9ac3356c-4ea4-4814-84c3-235484f2ef19c"> </a><a name="hc9ac3356c-4ea4-4814-84c3-235484f2ef19c"> </a><a name="9ac3356c-4ea4-4814-84c3-235484f2ef19c-en-US"> </a><p><b>code</b>: <span title="Codes:{https://www.who-umc.org/phpid 0xF79CABF272B6A7EEF104DDDA44E82716}">Enbrel Etanercept 25 mg powder for solution for injection</span></p><p><b>form</b>: <span title="Codes:{http://standardterms.edqm.eu 50041500}">Powder and solution for solution for injection</span></p><h3>Ingredients</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fdasis.nlm.nih.gov OP401G7OJC}">Enbrel Etanercept 25 mg</span></td></tr></table></div>
</text>
<code>
<coding>
<system value="https://www.who-umc.org/phpid"/>
<code value="0xF79CABF272B6A7EEF104DDDA44E82716"/>
<display
value="Enbrel Etanercept 25 mg powder for solution for injection"/>
</coding>
</code>
<form>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="50041500"/>
<display value="Powder and solution for solution for injection"/>
</coding>
<text value="Powder and solution for solution for injection"/>
</form>
<ingredient>
<itemCodeableConcept>
<coding>
<system value="http://fdasis.nlm.nih.gov"/>
<code value="OP401G7OJC"/>
<display value="ETANERCEPT (ENBREL)"/>
</coding>
<text value="Enbrel Etanercept 25 mg"/>
</itemCodeableConcept>
</ingredient>
</Medication>
</resource>
</entry>
<entry>
<fullUrl
value="https://myserver.org/Medication/9ac3356c-4ea4-4814-84c3-235484f2jk99c"/>
<resource>
<Medication>
<id value="9ac3356c-4ea4-4814-84c3-235484f2jk99c"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ips/StructureDefinition/Medication-uv-ips"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Medication_9ac3356c-4ea4-4814-84c3-235484f2jk99c"> </a><p class="res-header-id"><b>Generated Narrative: Medication 9ac3356c-4ea4-4814-84c3-235484f2jk99c</b></p><a name="9ac3356c-4ea4-4814-84c3-235484f2jk99c"> </a><a name="hc9ac3356c-4ea4-4814-84c3-235484f2jk99c"> </a><a name="9ac3356c-4ea4-4814-84c3-235484f2jk99c-en-US"> </a><p><b>code</b>: <span title="Codes:{http://iyaku.info/medicine/ 1139002F1070}, {https://www.who-umc.org/phpid 5C62673C79E096D37914D32A45AA8F4D}, {https://www.who-umc.org/phpid FB9808F4FED210183F412F9998622287}">Tegretol Carbamazepine 200 mg tablets</span></p><p><b>form</b>: <span title="Codes:{http://standardterms.edqm.eu 10219000}">Tablet</span></p><h3>Ingredients</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fdasis.nlm.nih.gov 33CM23913M}">CARBAMAZEPINE</span></td></tr></table></div>
</text>
<code>
<coding>
<system value="http://iyaku.info/medicine/"/>
<code value="1139002F1070"/>
</coding>
<coding>
<system value="https://www.who-umc.org/phpid"/>
<code value="5C62673C79E096D37914D32A45AA8F4D"/>
<display value="Tegretol Carbamazepine 200 mg tablets"/>
</coding>
<coding>
<system value="https://www.who-umc.org/phpid"/>
<code value="FB9808F4FED210183F412F9998622287"/>
<display value="Tegretol Carbamazepine 200 mg tablets"/>
</coding>
</code>
<form>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="10219000"/>
<display value="Tablet"/>
</coding>
</form>
<ingredient>
<itemCodeableConcept>
<coding>
<system value="http://fdasis.nlm.nih.gov"/>
<code value="33CM23913M"/>
<display value="CARBAMAZEPINE"/>
</coding>
<text value="CARBAMAZEPINE"/>
</itemCodeableConcept>
</ingredient>
</Medication>
</resource>
</entry>
</Bundle>
IG © 2021+ . Package hl7.eu.fhir.gh-ips#0.1.0 based on FHIR 4.0.1. Generated 2024-10-01
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
